News

The studies, funded by the National Institutes for Health’s CounterACT program, have been designed to test the efficacy of AEOL 10150 as a treatment for damage to the

This change follows the resignation of Richard Donnelly from his roles as an officer and director of AspenBio. Mr Donnelly has indicated that he plans to pursue other

Through this agreement, BioWisdom gains access to the data within Asterand’s proprietary Target Evaluator database. The database consists of quantitative human gene expression profiles that chart the expression

Curis, a drug development company, has announced that its collaborator Genentech and the National Cancer Institute’s division of cancer treatment and diagnosis are planning to enter into a

The license grants Fovea exclusive marketing rights for DX-88 in ophthalmic indications in the EU. Dyax retains marketing rights for these indications for all territories outside the EU.

These data suggest that GS 9350 has significant and selective pharmacoenhancing ability, no antiviral activity against HIV and differentiated biological properties in vitro compared to ritonavir, currently the

This includes $191 million of revenue from its recent acquisition of Applied Biosystems (AB), which closed on November 21, 2008. The closing date of the transaction resulted in

The improved delivery catheter enhances the previous version of the Gore Tag thoracic endoprosthesis by adding a soft flexible tip to the leading end of the delivery system.

The action is part of an overall cost-cutting program as the company works toward resuming full operation. The company has encountered a number of substantial challenges over the